Trial Profile
Planned phase I trials of ACTB 1003 in cancer
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 Nov 2011
Price :
$35
*
At a glance
- Drugs EOC 317 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 25 Nov 2011 New trial record